Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)